Metagenomi Therapeutics, Inc.
MGX
$1.16
-$0.01-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 120.66M | 140.16M | 160.80M | 184.11M | 204.99M |
| Total Receivables | 900.00K | 1.00M | 1.51M | 2.26M | 2.27M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.90M | 3.40M | 3.23M | 3.45M | 4.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 124.47M | 144.56M | 165.54M | 189.82M | 211.68M |
|
|
|||||
| Total Current Assets | 124.47M | 144.56M | 165.54M | 189.82M | 211.68M |
| Net Property, Plant & Equipment | 41.67M | 44.92M | 47.38M | 49.91M | 52.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.41M | 5.32M | 6.03M | 6.06M | 6.05M |
| Total Assets | 173.70M | 196.95M | 221.10M | 247.94M | 272.28M |
|
|
|||||
| Total Accounts Payable | 2.60M | 2.40M | 1.49M | 1.22M | 2.89M |
| Total Accrued Expenses | 7.60M | 4.68M | 6.72M | 9.90M | 5.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.24M | 6.11M | 6.03M | 5.57M | 5.51M |
| Total Finance Division Other Current Liabilities | 11.20M | 9.32M | 8.70M | 12.90M | 18.97M |
| Total Other Current Liabilities | 11.20M | 9.32M | 8.70M | 12.90M | 18.97M |
| Total Current Liabilities | 27.63M | 22.50M | 22.93M | 29.58M | 33.27M |
|
|
|||||
| Total Current Liabilities | 27.63M | 22.50M | 22.93M | 29.58M | 33.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 31.49M | 33.08M | 34.63M | 36.09M | 37.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.02M | 3.59M | 4.94M | 3.82M | 5.71M |
| Total Liabilities | 61.13M | 59.17M | 62.51M | 69.49M | 76.45M |
|
|
|||||
| Common Stock & APIC | 474.10M | 471.76M | 469.21M | 466.42M | 463.41M |
| Retained Earnings | -361.41M | -333.93M | -310.87M | -288.34M | -267.95M |
| Treasury Stock & Other | -122.00K | -44.00K | 260.00K | 371.00K | 372.00K |
| Total Common Equity | 112.57M | 137.79M | 158.60M | 178.45M | 195.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 112.57M | 137.79M | 158.60M | 178.45M | 195.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 112.57M | 137.79M | 158.60M | 178.45M | 195.83M |
|
|
|||||